BOUTROS, ANDREA
BOUTROS, ANDREA
100007 - Dipartimento di Medicina interna e specialità mediche
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis
2023-01-01 Boutros, Andrea; Tanda, Enrica Teresa; Croce, Elena; Catalano, Fabio; Ceppi, Marcello; Bruzzone, Marco; Cecchi, Federica; Arecco, Luca; Fraguglia, Matteo; Pronzato, Paolo; Genova, Carlo; Del Mastro, Lucia; Lambertini, Matteo; Spagnolo, Francesco
Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient
2020-01-01 Boutros, A.; Schiavi, C.; Cecchi, F.; Spagnolo, F.; Guadagno, A.; Tanda, E. T.; Giusti, F.; Murdaca, G.; Queirolo, P.
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients
2022-01-01 Boutros, Andrea; Vera, Lara; Gatto, Federico; Fornarini, Giuseppe; Zanardi, Elisa
Current State of Target Treatment in BRAF Mutated Melanoma
2020-01-01 Tanda, E. T.; Vanni, I.; Boutros, A.; Andreotti, V.; Bruno, W.; Ghiorzo, P.; Spagnolo, F.
Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma
2023-01-01 Boutros, Andrea; Croce, Elena; Tanda, Enrica Teresa; Cecchi, Federica; Arecco, Luca; Genova, Carlo; Baldelli, Ilaria; Lambertini, Matteo; Raposio, Edoardo; Del Mastro, Lucia; Spagnolo, Francesco
Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology
2023-01-01 Queirolo, P.; Cinquini, M.; Argenziano, G.; Bassetto, F.; Bossi, P.; Boutros, A.; Clemente, C.; de Giorgi, V.; Del Vecchio, M.; Patuzzo, R.; Peris, K.; Quaglino, P.; Reali, A.; Zalaudek, I.; Spagnolo, F.
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology
2024-01-01 Queirolo, P.; Cinquini, M.; Argenziano, G.; Bassetto, F.; Bossi, P.; Boutros, A.; Clemente, C.; de Giorgi, V.; Del Vecchio, M.; Patuzzo, R.; Pennachioli, E.; Peris, K.; Quaglino, P.; Reali, A.; Zalaudek, I.; Spagnolo, F.
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
2019-01-01 Queirolo, P.; Boutros, A.; Tanda, E.; Spagnolo, F.; Quaglino, P.
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
2021-01-01 Boutros, A.; Cecchi, F.; Tanda, E. T.; Croce, E.; Gili, R.; Arecco, L.; Spagnolo, F.; Queirolo, P.
Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
2021-01-01 Tanda, E. T.; D'Amato, A. L.; Rossi, G.; Croce, E.; Boutros, A.; Cecchi, F.; Spagnolo, F.; Queirolo, P.
Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma
2020-01-01 Spagnolo, F.; Croce, E.; Boutros, A.; Tanda, E.; Cecchi, F.; Mascherini, M.; Solari, N.; Cafiero, F.; Queirolo, P.
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
2023-01-01 Boutros, A; Bottini, A; Rossi, G; Tanda, E T; Spagnolo, F; Barletta, G; Croce, E; Fava, P; Parisi, A; De Rosa, F; Palla, M; Marconcini, R; Ferrari, M; Grandis, M; Spallarossa, P; Sarocchi, M; Arboscello, E; Del Mastro, L; Lambertini, M; Pronzato, P; Genova, C
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
2020-01-01 Vanni, I.; Tanda, E. T.; Dalmasso, B.; Pastorino, L.; Andreotti, V.; Bruno, W.; Boutros, A.; Spagnolo, F.; Ghiorzo, P.
Primary endobronchial melanoma: a case report and clinical management indications
2024-01-01 Barisione, Emanuela; Boutros, Andrea; Mora, Marco; Spagnolo, Francesco; Tanda, ENRICA TERESA; Genova, Carlo; Tagliabue, Elena
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis
2023-01-01 Arecco, L; Blondeaux, E; Bruzzone, M; Latocca, M M; Mariamidze, E; Begijanashvili, S; Sokolovic, E; Gentile, G; Scavone, G; Ottonello, S; Boutros, A; Vaz-Luis, I; Saura, C; Anderson, R A; Demeestere, I; Azim, H A; de Azambuja, E; Peccatori, F A; Del Mastro, L; Partridge, A H; Lambertini, M
The adjuvant treatment revolution for high-risk melanoma patients
2019-01-01 Spagnolo, F.; Boutros, A.; Tanda, E.; Queirolo, P.
The treatment of advanced melanoma: Current approaches and new challenges
2024-01-01 Boutros, A.; Croce, E.; Ferrari, M.; Gili, R.; Massaro, G.; Marconcini, R.; Arecco, L.; Tanda, E. T.; Spagnolo, F.
Tisotumab vedotin
2020-01-01 D'Alessandro, G.; Barra, F.; Boutros, A.; Evangelisti, G.; Desideri, L. F.; Moioli, M.; Ferrero, S.
Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review
2021-01-01 Spagnolo, F.; Boutros, A.; Cecchi, F.; Croce, E.; Tanda, E. T.; Queirolo, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis | 1-gen-2023 | Boutros, Andrea; Tanda, Enrica Teresa; Croce, Elena; Catalano, Fabio; Ceppi, Marcello; Bruzzone, Marco; Cecchi, Federica; Arecco, Luca; Fraguglia, Matteo; Pronzato, Paolo; Genova, Carlo; Del Mastro, Lucia; Lambertini, Matteo; Spagnolo, Francesco | |
| Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient | 1-gen-2020 | Boutros, A.; Schiavi, C.; Cecchi, F.; Spagnolo, F.; Guadagno, A.; Tanda, E. T.; Giusti, F.; Murdaca, G.; Queirolo, P. | |
| Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients | 1-gen-2022 | Boutros, Andrea; Vera, Lara; Gatto, Federico; Fornarini, Giuseppe; Zanardi, Elisa | |
| Current State of Target Treatment in BRAF Mutated Melanoma | 1-gen-2020 | Tanda, E. T.; Vanni, I.; Boutros, A.; Andreotti, V.; Bruno, W.; Ghiorzo, P.; Spagnolo, F. | |
| Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma | 1-gen-2023 | Boutros, Andrea; Croce, Elena; Tanda, Enrica Teresa; Cecchi, Federica; Arecco, Luca; Genova, Carlo; Baldelli, Ilaria; Lambertini, Matteo; Raposio, Edoardo; Del Mastro, Lucia; Spagnolo, Francesco | |
| Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology | 1-gen-2023 | Queirolo, P.; Cinquini, M.; Argenziano, G.; Bassetto, F.; Bossi, P.; Boutros, A.; Clemente, C.; de Giorgi, V.; Del Vecchio, M.; Patuzzo, R.; Peris, K.; Quaglino, P.; Reali, A.; Zalaudek, I.; Spagnolo, F. | |
| Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology | 1-gen-2024 | Queirolo, P.; Cinquini, M.; Argenziano, G.; Bassetto, F.; Bossi, P.; Boutros, A.; Clemente, C.; de Giorgi, V.; Del Vecchio, M.; Patuzzo, R.; Pennachioli, E.; Peris, K.; Quaglino, P.; Reali, A.; Zalaudek, I.; Spagnolo, F. | |
| Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy | 1-gen-2019 | Queirolo, P.; Boutros, A.; Tanda, E.; Spagnolo, F.; Quaglino, P. | |
| Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma | 1-gen-2021 | Boutros, A.; Cecchi, F.; Tanda, E. T.; Croce, E.; Gili, R.; Arecco, L.; Spagnolo, F.; Queirolo, P. | |
| Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale? | 1-gen-2021 | Tanda, E. T.; D'Amato, A. L.; Rossi, G.; Croce, E.; Boutros, A.; Cecchi, F.; Spagnolo, F.; Queirolo, P. | |
| Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma | 1-gen-2020 | Spagnolo, F.; Croce, E.; Boutros, A.; Tanda, E.; Cecchi, F.; Mascherini, M.; Solari, N.; Cafiero, F.; Queirolo, P. | |
| Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature | 1-gen-2023 | Boutros, A; Bottini, A; Rossi, G; Tanda, E T; Spagnolo, F; Barletta, G; Croce, E; Fava, P; Parisi, A; De Rosa, F; Palla, M; Marconcini, R; Ferrari, M; Grandis, M; Spallarossa, P; Sarocchi, M; Arboscello, E; Del Mastro, L; Lambertini, M; Pronzato, P; Genova, C | |
| Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications | 1-gen-2020 | Vanni, I.; Tanda, E. T.; Dalmasso, B.; Pastorino, L.; Andreotti, V.; Bruno, W.; Boutros, A.; Spagnolo, F.; Ghiorzo, P. | |
| Primary endobronchial melanoma: a case report and clinical management indications | 1-gen-2024 | Barisione, Emanuela; Boutros, Andrea; Mora, Marco; Spagnolo, Francesco; Tanda, ENRICA TERESA; Genova, Carlo; Tagliabue, Elena | |
| Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis | 1-gen-2023 | Arecco, L; Blondeaux, E; Bruzzone, M; Latocca, M M; Mariamidze, E; Begijanashvili, S; Sokolovic, E; Gentile, G; Scavone, G; Ottonello, S; Boutros, A; Vaz-Luis, I; Saura, C; Anderson, R A; Demeestere, I; Azim, H A; de Azambuja, E; Peccatori, F A; Del Mastro, L; Partridge, A H; Lambertini, M | |
| The adjuvant treatment revolution for high-risk melanoma patients | 1-gen-2019 | Spagnolo, F.; Boutros, A.; Tanda, E.; Queirolo, P. | |
| The treatment of advanced melanoma: Current approaches and new challenges | 1-gen-2024 | Boutros, A.; Croce, E.; Ferrari, M.; Gili, R.; Massaro, G.; Marconcini, R.; Arecco, L.; Tanda, E. T.; Spagnolo, F. | |
| Tisotumab vedotin | 1-gen-2020 | D'Alessandro, G.; Barra, F.; Boutros, A.; Evangelisti, G.; Desideri, L. F.; Moioli, M.; Ferrero, S. | |
| Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review | 1-gen-2021 | Spagnolo, F.; Boutros, A.; Cecchi, F.; Croce, E.; Tanda, E. T.; Queirolo, P. |